Related Experiment Video
Updated: Dec 10, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Cyto-biological effects of microRNA-424-5p on human colorectal cancer cells
Weitao Yan1,2, Xia Jiang1, Guiqi Wang1
1Department of General Surgery, Hebei Key Laboratory of Colorectal Cancer Precision Diagnosis and Treatment, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China.
Abstract:
MicroRNA (miR)-424-5p is overexpressed in colorectal cancer (CRC); however, its role, clinical significance and underlying molecular mechanism have remained to be fully elucidated. The aim of the present study was to investigate the roles of miR-424-5p in CRC and the underlying mechanisms. It was demonstrated that miR-424-5p is overexpressed in CRC, based on bioinformatics analysis using The Cancer Genome Atlas TCGA and analysis of tissue samples from patients with CRC from The First Hospital of Hebei Medical University, and the expression of miR-424-5p was associated with the depth of invasion and Dukes' staging. In CRC cells, the oncogenic roles of miR-424-5p were also verified by Cell Counting Kit-8, wound healing and Transwell assays. To identify target genes, all transcripts were compared between miR-424-5p mimic-transfected SW480 cells and mimic control cells by transcriptome sequencing. Subsequently, the differentially expressed genes (DEGs) were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. The DEGs were revealed to be significantly enriched in the GO terms 'serine hydrolase activity,' 'serine-type peptidase activity' and 'serine-type endopeptidase activity'. KEGG signaling pathway analysis indicated that the DEGs were significantly enriched in 'endocytosis', 'regulation of actin cytoskeleton', 'Wnt signaling pathway' and 'ubiquitin-mediated proteolysis signaling pathway'. These results suggested that miR-424-5p is a potential target in the treatment of CRC.
Insights
MicroRNA-424-5p is overexpressed in colorectal cancer (CRC), promoting tumor progression. This study identifies miR-424-5p as a potential therapeutic target for CRC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA (miR)-424-5p is frequently overexpressed in colorectal cancer (CRC).
- The precise function, clinical relevance, and molecular mechanisms of miR-424-5p in CRC remain incompletely understood.
- Understanding miR-424-5p's role is crucial for developing novel CRC therapies.
Purpose of the Study:
- To investigate the functional roles of miR-424-5p in colorectal cancer.
- To elucidate the underlying molecular mechanisms driving miR-424-5p's involvement in CRC.
- To assess the clinical significance and therapeutic potential of miR-424-5p in CRC.
Main Methods:
- Bioinformatic analysis using The Cancer Genome Atlas (TCGA) and patient tissue samples.
- In vitro assays including Cell Counting Kit-8, wound healing, and Transwell assays in CRC cells.
- Transcriptome sequencing followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.
Main Results:
- miR-424-5p is significantly overexpressed in CRC tissues and correlated with invasion depth and Dukes' staging.
- miR-424-5p exhibits oncogenic properties, promoting CRC cell proliferation and migration in vitro.
- Transcriptome analysis identified target genes enriched in serine hydrolase activity, endocytosis, and Wnt signaling pathways.
Conclusions:
- miR-424-5p plays a significant oncogenic role in colorectal cancer progression.
- The molecular pathways regulated by miR-424-5p provide insights into CRC pathogenesis.
- miR-424-5p represents a promising molecular target for future CRC therapeutic strategies.
More Related Videos
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
Related Concept Videos
MicroRNAs
MicroRNAs
Drugs that Stabilize Microtubules
Abnormal Proliferation